Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004317817 | SCV003982861 | uncertain significance | not specified | 2023-05-18 | criteria provided, single submitter | clinical testing | The c.1645C>A (p.P549T) alteration is located in exon 3 (coding exon 3) of the NPC1L1 gene. This alteration results from a C to A substitution at nucleotide position 1645, causing the proline (P) at amino acid position 549 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |